TITLE

Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease

AUTHOR(S)
Palmer, L. B.; Greenberg, H. E.; Schiff, M. J.
PUB. DATE
January 1991
SOURCE
Thorax;Jan1991, Vol. 46 Issue 1, p15
SOURCE TYPE
Academic Journal
DOC. TYPE
journal article
ABSTRACT
No abstract available.
ACCESSION #
66019544

 

Related Articles

  • Chapter 5 - Aspergillosis: from diagnosis to treatment. Uchoa Sales, Maria da Penha // Jornal Brasileiro de Pneumologia;dec2009, Vol. 35 Issue 12, p1238 

    Aspergillosis is a multifaceted disease whose clinical manifestations (allergic, saprophytic and invasive forms) are determined by the host immune response. Allergic bronchopulmonary aspergillosis is characterized by corticosteroid-dependent asthma, fever, hemoptysis and destruction of the...

  • The Clinical relevance of Aspergillus isolation from respiratory tract samples & detection of Aspergillus galactomannan antigen in serum of patients with acute exacerbation of COPD. Fouad, Lamia; Fathi, Marwa S.; ElMaraghy, Ashraf A. // Nature & Science;Jan2013, Vol. 11 Issue 1, p40 

    Acute invasive aspergillosis is a devastating opportunistic infection in the severely immunocompromised. Patients at risk for invasive aspergillosis include those with prolonged neutropenia (e.g., following cytotoxic regimens for acute leukemia), hematopoietic stem cell transplant (HSCT)...

  • Enhancing Angiogenesis in Invasive Aspergillosis: A Novel Therapeutic Approach. Ito, James I. // Journal of Infectious Diseases;Apr2013, Vol. 207 Issue 7, p1031 

    The article offers information on risk factors for invasive aspergillosis and discusses the study of R. Ben-Ami and colleagues related to angiogenesis in a neutropenic model of cutaneous invasive aspergillosis. As mentioned, risk factors for invasive aspergillosis are neutropenia and...

  • The Impact of Culture Isolation of Aspergillus Species: A Hospital-Based Survey of Aspergillosis. Perfect, R.; Cox, G.M.; Lee, J.Y.; Kauffman, C.A.; de Repentigny, L.; Chapman, S.W.; Morrison, V.A.; Pappas, P.; Hiemenz, J.W.; Stevens, D.A. // Clinical Infectious Diseases;12/1/2001, Vol. 33 Issue 11, p1824 

    The term "spergillosis"comprises several categories of infection: invasive aspergillosis; chronic necrotizing aspergillosis; aspergilloma, or fungus ball; and allergic bronchopulmonary aspergillosis. In 24 medical centers, we examined the impact of a culture positive for Aspergillus species on...

  • Primary Aspergillosis of the Larynx. Law, Richard H.; Reyes, Samuel A. // Case Reports in Otolaryngology;2/3/2016, p1 

    Laryngeal aspergillosis is most commonly seen as a result of secondary invasion from the lungs and tracheobronchial tree in immunocompromised hosts. Primary aspergillosis of the larynx is, however, rare with few cases documented over the past fifty years. We report a case of a 73-year-old woman...

  • Voriconazole.  // Reactions Weekly;12/19/2015, Vol. 1582 Issue 1, p430 

    The article describes three cases of neurological symptoms that developed in lung transplant patients during treatment with voriconazole along with corticosteroids as a prophylaxis against aspergillosis.

  • Co-infection with invasive pulmonary aspergillosis and Pneumocystis jirovecii pneumonia after corticosteroid therapy. Hagiya, Hideharu; Miyake, Takayoshi; Kokumai, Yusuke; Murase, Tomoko; Kuroe, Yasutoshi; Nojima, Hiroyoshi; Sugiyama, Junichi; Naito, Hiromichi; Hagioka, Shingo; Morimoto, Naoki // Journal of Infection & Chemotherapy;Apr2013, Vol. 19 Issue 2, p342 

    A 95-year-old man with chronic obstructive pulmonary disease and chronic hepatitis C virus infection was treated for acute lung injury caused by Chlamydophila pneumoniae with antibiotics and high-dose corticosteroids. In total, 7,500 mg methylprednisolone and 680 mg prednisolone were...

  • The clinical spectrum of pulmonary aspergillosis. Kosmidis, Chris; Denning, David W // Postgraduate Medical Journal;Jul2015, Vol. 91 Issue 1077, p403 

    The clinical presentation of Aspergillus lung disease is determined by the interaction between fungus and host. Invasive aspergillosis develops in severely immunocompromised patients, including those with neutropenia, and increasingly in the non-neutropenic host, including lung transplant...

  • The clinical spectrum of pulmonary aspergillosis. Kosmidis, Chris; Denning, David W. // Thorax;Mar2015, Vol. 70 Issue 3, p270 

    The clinical presentation of Aspergillus lung disease is determined by the interaction between fungus and host. Invasive aspergillosis develops in severely immunocompromised patients, including those with neutropenia, and increasingly in the non-neutropenic host, including lung transplant...

  • Immune reconstitution/ Aspergillus infections in allogenic stem cell transplant recipients: have we made any progress? Jantunen, E.; Anttila, V.-J.; Ruutu, T. // Bone Marrow Transplantation;12/15/2002, Vol. 30 Issue 12, p925 

    Summarizes data on invasive aspergillosis (IA) infections in allogeneic stem cell transplant recipients to assess whether there has been progress in the treatment of the disease. Epidemiology and risk factors of IA; Advances in the diagnosis of the disease; Treatment measures.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics